Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4162555
- 227 Pages
- October 2020
- Pharmaceuticals
Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore, maintain, or improve tissue function. In addition, for this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs.
The tissue engineering market is anticipated to grow significantly during the forecast period, owing to increase in prevalence of chronic diseases & trauma emergencies, rise in awareness related to tissue engineering, and potential pipeline products. Furthermore, growth in number of R&D activities with rise in awareness of tissue engineering in emerging economies are expected to support the market growth. Developed nations have adopted technological advancements in tissue engineering and regenerative medicine sectors, which help in expansion of the global market. In addition, increase in focus of key players on tissue engineering based therapies are expected to enhance the tissue engineering market growth during the forecast period. However, stringent government regulations and high cost of treatment are estimated to hamper growth of the market.
The global tissue engineering market is segmented into type, application, and region. On the basis of type, the market is categorized into synthetic scaffold material, biologically derived scaffold material, and others. The synthetic scaffold material segment is further categorized into synthetic polymer and others. The biologically derived scaffold material segment is bifurcated into collagen and others. On the basis of application, the market is segregated into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
• Synthetic Scaffold Material
o Synthetic Polymer
o Others
• Biologically Derived Scaffold Material
o Collagen
o Others
• Others
By Application
• Orthopedics & Musculoskeletal
• Neurology
• Cardiovascular
• Skin & Integumentary
• Dental
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Latin America
o Middle East and Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• AbbVie Inc. (Allergen Plc.)
• B. Braun Melsungen AG
• Becton, Dickinson and Company (C. R. BARD, INC.)
• Integra LifeSciences
• Organogenesis Holdings
• Sid Martin Biotech (Axogen)
• Smith & Nephew Plc. (Osiris Therapeutics)
• TissueTech Inc.
• Vericel Corporation
• Zimmer Biomet Holdings, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• Modex Therapeutics
• Biotime Inc
• Sanofi (Genzyme)
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
Chapter 2:Executive Summary
2.1.Key findings of the study
2.2.CXO perspective
Chapter 3:Market landscape
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in need for tissue engineering in organ transplantation
3.5.1.2.Advancements in medical equipment technologies
3.5.1.3.Increase in prevalence of chronic diseases and trauma emergencies
3.5.2.Restraint
3.5.2.1.High cost associated with tissue engineered products
3.5.2.2.Hurdles associated with tissue engineering
3.5.3.Opportunity
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.Market information on kidney and liver tissue engineering
3.7.Market overview: product segment
3.7.1.Cell Therapy
3.7.2.Gene Therapy
3.7.3.Small molecules and biologics
3.8.COVID-19 impact analysis on tissue engineering market
Chapter 4:Tissue Engineering MARKET, BY type
4.1.Overview
4.1.1.Market size and forecast
4.2.Synthetic scaffold material
4.2.1.Key market trends growth factors and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Synthetic polymer
4.2.2.2.Others
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Biologically derived scaffold materials
4.3.1.Key market trends growth factors and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Collagen
4.3.2.2.Others
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
Chapter 5:Tissue Engineering MARKET, BY Application
5.1.Overview
5.1.1.Market size and forecast
5.2.Orthopedics & musculoskeletal
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Neurology
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Cardiovascular
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Skin & integumentary
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Dental
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
5.7.Others
5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country
Chapter 6:Tissue Engineering MARKET, BY Region
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, key growth factors and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. tissue engineering market, by type
6.2.2.1.2.U.S. tissue engineering market, by application
6.2.2.2.Canada
6.2.2.2.1.Canada tissue engineering market, by type
6.2.2.2.2.Canada tissue engineering market, by application
6.2.2.3.Mexico
6.2.2.3.1.Mexico tissue engineering market, by type
6.2.2.3.2.Mexico tissue engineering market, by application
6.2.3.North America market size and forecast, by type
6.2.4.North America market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany tissue engineering market, by type
6.3.2.1.2.Germany tissue engineering market, by application
6.3.2.2.France
6.3.2.2.1.France tissue engineering market, by type
6.3.2.2.2.France tissue engineering market, by application
6.3.2.3.UK
6.3.2.3.1.UK tissue engineering market, by type
6.3.2.3.2.UK tissue engineering market, by application
6.3.2.4.Italy
6.3.2.4.1.Italy tissue engineering market, by type
6.3.2.4.2.Italy tissue engineering market, by application
6.3.2.5.Spain
6.3.2.5.1.Spain tissue engineering market, by type
6.3.2.5.2.Spain tissue engineering market, by application
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe tissue engineering market, by type
6.3.2.6.2.Rest of Europe tissue engineering market, by application
6.3.3.Europe market size and forecast, by type
6.3.4.Europe market size and forecast, by application
6.4.Asia-pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.4.2.1.Japan
6.4.2.1.1.Japan tissue engineering market, by type
6.4.2.1.2.Japan tissue engineering market, by application
6.4.2.2.China
6.4.2.2.1.China tissue engineering market, by type
6.4.2.2.2.China tissue engineering market, by application
6.4.2.3.Australia
6.4.2.3.1.Australia tissue engineering market, by type
6.4.2.3.2.Australia tissue engineering market, by application
6.4.2.4.India
6.4.2.4.1.India tissue engineering market, by type
6.4.2.4.2.India tissue engineering market, by application
6.4.2.5.South Korea
6.4.2.5.1.South Korea tissue engineering market, by type
6.4.2.5.2.South Korea tissue engineering market, by application
6.4.2.6.Rest of Asia-Pacific market size and forecast
6.4.2.6.1.Rest of Asia-Pacific tissue engineering market, by type
6.4.2.6.2.Rest of Asia-Pacific tissue engineering market, by application
6.4.3.Asia-pacific market size and forecast, by type
6.4.4.Asia-pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.5.2.1.Latin America
6.5.2.1.1.Latin America tissue engineering market, by type
6.5.2.1.2.Latin America tissue engineering market, by application
6.5.2.2.Middle East & Africa
6.5.2.2.1.Middle East & Africa tissue engineering market, by type
6.5.2.2.2.Middle East & Africa tissue engineering market, by application
6.5.3.LAMEA market size and forecast, by type
6.5.4.LAMEA market size and forecast, by application
Chapter 7:Company profiles
7.1.ABBVIE INC. (ALLERGEN PLC.)
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.B. BRAUN MELSUNGEN AG
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.INTEGRA LIFESCIENCES
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.ORGANOGENESIS HOLDINGS
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.SID MARTIN BIOTECH (AXOGEN)
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments
7.8.TISSUETECH INC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.9.VERICEL CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance.
7.9.6.Key strategic moves and developments
7.10.ZIMMER BIOMET HOLDINGS, INC.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.BUSINESS PERFORMANCE
TABLE 01.GLOBAL TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.GLOBAL SYNTHETIC SCAFFOLD MATERIAL MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.SYNTHETIC SCAFFOLD MATERIAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BIOLOGICALLY DERIVED SCAFFOLD MATERIAL MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 05.BIOLOGICALLY DERIVED SCAFFOLD MATERIALS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 08.ORTHOPEDICS & MUSCULOSKELETAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.NEUROLOGY TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.CARDIOVASCULAR TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 11.SKIN & INTEGUMENTARY TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 12.DENTAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.GLOBAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NORTH AMERICA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 16.U.S. TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 17.U.S. TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 18.CANADA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.CANADA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 20.MEXICO TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.EUROPE TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.GERMANY TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 26.GERMANY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 27.FRANCE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 28.FRANCE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 29.UK TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 30.UK TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 31.ITALY TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 32.ITALY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 33.SPAIN TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 34.SPAIN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 35.REST OF EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.REST OF EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 37.EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 38.EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 40.JAPAN TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.JAPAN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 42.CHINA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 43.CHINA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 44.AUSTRALIA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 45.AUSTRALIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 46.INDIA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 47.INDIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 48.SOUTH KOREA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 49.SOUTH KOREA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 52.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 53.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 54.LAMEA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 55.LATIN AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 56.LATIN AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 57.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 58.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 59.LAMEA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 60.LAMEA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.ABBVIE: COMPANY SNAPSHOT
TABLE 62.ABBVIE: OERATING SEGMENT
TABLE 63.ABBVIE: PRODUCT PORTFOLIO
TABLE 64.ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65.B BRAUN: COMPANY SNAPSHOT
TABLE 66.B BRAUN: PRODUCT SEGMENTS
TABLE 67.B BRAUN: PRODUCT PORTFOLIO
TABLE 68.BD: COMPANY SNAPSHOT
TABLE 69.BD: OERATING SEGMENT
TABLE 70.BD: PRODUCT PORTFOLIO
TABLE 71.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 72.INTEGRA: COMPANY SNAPSHOT
TABLE 73.INTEGRA: OPERATING BUSINESS SEGMENTS
TABLE 74.INTEGRA: PRODUCT PORTFOLIO
TABLE 75.ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 76.ORGANOGENESIS: OPERATING SEGMENTS
TABLE 77.ORGANOGENESIS: PRODUCT PORTFOLIO
TABLE 78.AXOGEN: COMPANY SNAPSHOT
TABLE 79.AXOGEN: OPERATING SEGMENTS
TABLE 80.AXOGEN: PRODUCT PORTFOLIO
TABLE 81.AXOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 82.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 83.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 84.SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 85.TISSUETECH: COMPANY SNAPSHOT
TABLE 86.TISSUETECH: OPERATING BUSINESS SEGMENTS
TABLE 87.HOLOGIC: PRODUCT PORTFOLIO
TABLE 88.VERICEL: COMPANY SNAPSHOT
TABLE 89.VERICEL: OPERATING SEGMENTS
TABLE 90.VERICEL: PRODUCT PORTFOLIO
TABLE 91.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 92.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 93.ZIMMER BIOMET: PRODUCT PORTFOLIO
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
